ClinicalTrials.gg
Not yet recruitingNCT07936695Updated Nov 13, 2026

Lower Extremity Edema Among Nursing Students During Classroom Instruction and Clinical Practicum

An observational study in Lower Extremity Edema, sponsored by National Taiwan University Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by National Taiwan University Hospital · Observational

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn about the changes in lower leg swelling in nursing students during different learning activities. The main questions it aims to answer are:

Does lower leg swelling differ between long classroom days and clinical internship days? How does hourly walking activity affect lower leg fluid buildup? Participants will have their data collected on 1 classroom day (over 6 hours) and 1 clinical internship day (8 hours). Data collected includes basic information, total step counts, and lower leg fluid levels measured with a painless, non-invasive device (Moisture Meter D).

02

Conditions studied

  • Lower Extremity Edema

Keywords

  • Nursing students
  • lower extremity edema
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,617 studies on the registry; 578 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

undergraduate nursing students

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Third- or fourth-year undergraduate students currently enrolled in the School of Nursing, College of Medicine, National Taiwan University.
  • Aged 18 years or older (≥18 years of age).
  • Active users of an Apple iPhone who agree to authorize researchers to access their hourly step data via the Apple Health app during the study period.

Exclusion criteria

Exclusion Criteria:

  • Individuals with a known systemic disease causing lower-limb or peripheral edema.
  • Individuals with open wounds or skin infections at the foot measurement site.
  • Individuals using medical-grade compression stockings, or taking medications/supplements that alter fluid balance during the study period.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. subcutaneous moisture

    The Moisture Meter D portable tissue moisture analyzer (Delfin Technologies Ltd., Kuopio, Finland) will be used to measure the moisture content of local tissues in the lower limbs and feet of the participants.

    Time frame: From the time at baseline (before instruction/internship) and immediately after completion (post-instruction/internship) on both the classroom day and the clinical internship day (4 measurement time points in total per participant).

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Nov 2027, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 13, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
Nov 4, 2027
CompletionEst.
Nov 4, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07936695
Collaborators
National Taiwan University
Responsible party
Sponsor
First posted
Nov 13, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Nov 4, 2027 (estimated)
Completion
Nov 4, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Hsiao Ling Yang, PhD
Contact
slyang@ntu.edu.tw
+886 2-23123456 ext. 288895

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion